Fierce BioBiotech
Odyssey charts fresh voyage to public markets after abandoning IPO plans last year
Summary
In another sign that the biotech IPO market is heating back up, Odyssey Therapeutics has made a fresh announcement of its intention to go public.
In another sign that the biotech IPO market is heating back up, Odyssey Therapeutics has made a fresh announcement of its intention to go public.